Summary
Global Monoclonal Antibody Diagnostic Reagent Market Opportunities and Forecast 2022-2029
Market Overview The global Monoclonal Antibody Diagnostic Reagent Market is expected to grow at a CAGR of 7.8% from 2022 to 2029, owing to the increasing prevalence of autoimmune diseases and increasing demand for early diagnosis of such diseases.
Monoclonal antibodies (mAbs) are the latest and most advanced class of diagnostic reagents. These proteins bind specifically to a target molecule and can be used in many different tests, including immunoassays and Flow Cytometry. Growing awareness about mAb diagnostics among healthcare providers and increasing investment in R&D are key factors driving the growth of the global monoclonal antibody diagnostic reagent market
The market is divided into three segments: laboratory diagnostics, medical devices, and research & development. The laboratory diagnostics segment is expected to account for the largest share of the market in 2029, followed by medical devices and research & development.
Report Includes An overview of the global Monoclonal Antibody Diagnostic Reagent market, and related technologies and developments. Analyses of global market trends, with historical data from 2018, 2019, and 2020 estimates and projections of CAGRs through 2029. It also includes breakdowns of the overall Monoclonal Antibody Diagnostic Reagent market along with various segments, and by geographic region. Analysis of the stakeholder value chain in the Monoclonal Antibody Diagnostic Reagent market and comprehensive profiles of leading companies in the industry
Report Scope The report forecasts the size of the Monoclonal Antibody Diagnostic Reagent market for components from 2022 through 2029
The Executive Summary provides a snapshot of the key findings of the report. The introduction chapter includes the research scope, market segmentation, research methodology, and definitions and assumptions. It involves extremely rigorous scientific methods, tools, and techniques to estimate the market size. Exhaustive secondary research is being carried out to collect information related to the market, the parent market, and the peer market. Primary research is undertaken to validate the assumptions, findings, and sizing with industry experts and professionals across the value chain of the market. Both top-down and bottom-up approaches are employed to estimate the complete market size.
The chapter on market dynamics includes market drivers, restraints, and opportunities which helps familiarise with market potential and upcoming opportunities. The chapter on key insights includes emerging trends from major countries, the latest technological advancement, regulatory landscape, SWOT analysis, and Porter's five forces analysis. This chapter provides detailed insights into the market which derives the market trends, changing phase of investments, and the scope of profit potential, and helps to take appropriate business decisions. The chapter on competitive analysis includes the profiling of leading companies in the global market to map the leading companies and their focus of interest in the market.
After deriving the market size from the market size estimation process, the total market has been split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments, data triangulation and market breakdown procedures are being used. The data triangulation is carried out by studying various factors and trends from demand and supply perspectives.
Segmentation Analysis The global Monoclonal Antibody Diagnostic Reagent market is segmented on the basis of Type, Application, and Region.
Global Monoclonal Antibody Diagnostic Reagent Market Competitive Analysis:
Key players in the Global Monoclonal Antibody Diagnostic Reagent market are AnaSpec, BioGenex, Bio-Rad, Biocare Medical, BioVision, Celltrion, Creative Diagnostics, GenWay Biotech, Innovent Biologics, Medix Biochemica, Qiagen, Teva Pharmaceutical Ltd., Other prominent players.
*All our reports are customizable as per customer requirements This study forecasts revenue and volume growth at global, regional, and country levels from 2018 to 2029. The Global Monoclonal Antibody Diagnostic Reagent market is distributed on the basis of the below-mentioned segments:
Global Monoclonal Antibody Diagnostic Reagent Market, By Type:
Dot-immunogold Filtration Assay
Double Antigen Sandwich Chemiluminescence Method
Enzyme-Linked Immunosorbent Assay
Recombinant Immunoblot Assay
Global Monoclonal Antibody Diagnostic Reagent Market, By Application:
Hormones Diagnosis
Tumor Monitoring
Virus Detection
Global Monoclonal Antibody Diagnostic Reagent Market, By Region:
North America
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
South America
Brazil
Argentina
Rest of South America
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
Report Metric
Details
Market size available for years
2022–2029
Base year considered
2021
Forecast period
2022–2029
Forecast unit
Value (USD Million)
Segments Covered
Product, End Use, Application, and Region.
Regions covered
North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered
AnaSpec,BioGenex,Bio-Rad,Biocare Medical,BioVision,Celltrion,Creative Diagnostics,GenWay Biotech,Innovent Biologics,Medix Biochemica,Qiagen and,Teva Pharmaceutical Ltd.
Table of Contents
Monoclonal Antibody Diagnostic Reagent MARKET STUDY GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2022-2029
1. Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. Key Insights 4.1. Key Emerging Trends – For Major Countries 4.2. Latest Technological Advancement 4.3. Regulatory Landscape 4.4. Industry SWOT Analysis 4.5. Porters Five Forces Analysis 5. Global Monoclonal Antibody Diagnostic Reagent Market Analysis (USD Billion), Insights and Forecast, 2018-2029 5.1. Key Findings / Summary 5.2. Market Analysis, Insights and Forecast – By Segment 15.2.1. Sub-Segment 1 5.2.2. Sub-Segment 2 5.3. Market Analysis, Insights and Forecast – By Segment 25.3.1. Sub-Segment 1 5.3.2. Sub-Segment 2 5.3.3. Sub-Segment 3 5.3.4. Others 5.4. Market Analysis, Insights and Forecast – By Segment 35.4.1. Sub-Segment 1 5.4.2. Sub-Segment 2 5.4.3. Sub-Segment 3 5.4.4. Others 5.5. Market Analysis, Insights and Forecast – By Region5.5.1. North America 5.5.2. Latin America 5.5.3. Europe 5.5.4. Asia Pacific 5.5.5. Middle East and Africa 6. North America Monoclonal Antibody Diagnostic Reagent Market Analysis (USD Billion), Insights and Forecast, 2018-2029 6.1. Key Findings / Summary 6.2. Market Analysis, Insights and Forecast – By Segment 16.2.1. Sub-Segment 1 6.2.2. Sub-Segment 2 6.3. Market Analysis, Insights and Forecast – By Segment 26.3.1. Sub-Segment 1 6.3.2. Sub-Segment 2 6.3.3. Sub-Segment 3 6.3.4. Others 6.4. Market Analysis, Insights and Forecast – By Segment 36.4.1. Sub-Segment 1 6.4.2. Sub-Segment 2 6.4.3. Sub-Segment 3 6.4.4. Others 6.5. Market Analysis, Insights and Forecast – By Country 7. Latin America Monoclonal Antibody Diagnostic Reagent Market Analysis (USD Billion), Insights and Forecast, 2018-2029 7.1. Key Findings / Summary 7.2. Market Analysis, Insights and Forecast – By Segment 17.2.1. Sub-Segment 1 7.2.2. Sub-Segment 2 7.3. Market Analysis, Insights and Forecast – By Segment 27.3.1. Sub-Segment 1 7.3.2. Sub-Segment 2 7.3.3. Sub-Segment 3 7.3.4. Others 7.4. Market Analysis, Insights and Forecast – By Segment 37.4.1. Sub-Segment 1 7.4.2. Sub-Segment 2 7.4.3. Sub-Segment 3 7.4.4. Others 7.5. Insights and Forecast – By Country7.5.1. Brazil 7.5.2. Mexico 7.5.3. Rest of Latin America 8. Europe Monoclonal Antibody Diagnostic Reagent Market Analysis (USD Billion), Insights and Forecast, 2018-2029 8.1. Key Findings / Summary 8.2. Market Analysis, Insights and Forecast – By Segment 18.2.1. Sub-Segment 1 8.2.2. Sub-Segment 2 8.3. Market Analysis, Insights and Forecast – By Segment 28.3.1. Sub-Segment 1 8.3.2. Sub-Segment 2 8.3.3. Sub-Segment 3 8.3.4. Others 8.4. Market Analysis, Insights and Forecast – By Segment 38.4.1. Sub-Segment 1 8.4.2. Sub-Segment 2 8.4.3. Sub-Segment 3 8.4.4. Others 8.5. Market Analysis, Insights and Forecast – By Country8.5.1. UK 8.5.2. Germany 8.5.3. France 8.5.4. Italy 8.5.5. Spain 8.5.6. Russia 8.5.7. Rest of Europe 9. Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Analysis (USD Billion), Insights and Forecast, 2018-2029 9.1. Key Findings / Summary 9.2. Market Analysis, Insights and Forecast – By Segment 19.2.1. Sub-Segment 1 9.2.2. Sub-Segment 2 9.3. Market Analysis, Insights and Forecast – By Segment 29.3.1. Sub-Segment 1 9.3.2. Sub-Segment 2 9.3.3. Sub-Segment 3 9.3.4. Others 9.4. Market Analysis, Insights and Forecast – By Segment 39.4.1. Sub-Segment 1 9.4.2. Sub-Segment 2 9.4.3. Sub-Segment 3 9.4.4. Others 9.5. Market Analysis, Insights and Forecast – By Country9.5.1. China 9.5.2. India 9.5.3. Japan 9.5.4. Australia 9.5.5. South East Asia 9.5.6. Rest of Asia Pacific 10. Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Analysis (USD Billion), Insights and Forecast, 2018-2029 10.1. Key Findings / Summary 10.2. Market Analysis, Insights and Forecast – By Segment 110.2.1. Sub-Segment 1 10.2.2. Sub-Segment 2 10.3. Market Analysis, Insights and Forecast – By Segment 210.3.1. Sub-Segment 1 10.3.2. Sub-Segment 2 10.3.3. Sub-Segment 3 10.3.4. Others 10.4. Market Analysis, Insights and Forecast – By Segment 310.4.1. Sub-Segment 1 10.4.2. Sub-Segment 2 10.4.3. Sub-Segment 3 10.4.4. Others 10.5. Market Analysis, Insights and Forecast – By Country10.5.1. GCC 10.5.2. South Africa 10.5.3. Rest of Middle East & Africa 11. Competitive Analysis 11.1. Company Market Share Analysis, 2018 11.2. Key Industry Developments 11.3. Company Profile11.3.1. Company 111.3.1.1. Business Overview 11.3.1.2. Segment 1 & Service Offering 11.3.1.3. Overall Revenue 11.3.1.4. Geographic Presence 11.3.1.5. Recent Development *Similar details will be provided for the following companies11.3.2. Company 2 11.3.3. Company 3 11.3.4. Company 4 11.3.5. Company 5 11.3.6. Company 6 11.3.7. Company 7 11.3.8. Company 8 11.3.9. Company 9 11.3.10. Company 10 11.3.11. Company 11 11.3.12. Company 12
List of Figures
List of Figures
Figure 1: Global Monoclonal Antibody Diagnostic Reagent Market Revenue Breakdown (USD Billion, %) by Region, 2022 & 2029
Figure 2: Global Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 1, 2022 & 2029
Figure 3: Global Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 4: Global Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 5: Global Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 2, 2022 & 2029
Figure 6: Global Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 7: Global Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 8: Global Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 9: Global Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Others, 2018-2029
Figure 10: Global Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 3, 2022 & 2029
Figure 11: Global Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 12: Global Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 13: Global Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 14: Global Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Others, 2018-2029
Figure 15: Global Monoclonal Antibody Diagnostic Reagent Market Value (USD Billion), by Region, 2022 & 2029
Figure 16: North America Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 1, 2022 & 2029
Figure 17: North America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 18: North America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 19: North America Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 2, 2022 & 2029
Figure 20: North America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 21: North America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 22: North America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 23: North America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Others, 2018-2029
Figure 24: North America Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 3, 2022 & 2029
Figure 25: North America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 26: North America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 27: North America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 28: North America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Others, 2018-2029
Figure 29: North America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by U.S., 2018-2029
Figure 30: North America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Canada, 2018-2029
Figure 31: Latin America Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 1, 2022 & 2029
Figure 32: Latin America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 33: Latin America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 34: Latin America Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 2, 2022 & 2029
Figure 35: Latin America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 36: Latin America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 37: Latin America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 38: Latin America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Others, 2018-2029
Figure 39: Latin America Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 3, 2022 & 2029
Figure 40: Latin America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 41: Latin America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 42: Latin America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 43: Latin America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Others, 2018-2029
Figure 44: Latin America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Brazil, 2018-2029
Figure 45: Latin America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Mexico, 2018-2029
Figure 46: Latin America Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Rest of Latin America, 2018-2029
Figure 47: Europe Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 1, 2022 & 2029
Figure 48: Europe Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 49: Europe Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 50: Europe Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 2, 2022 & 2029
Figure 51: Europe Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 52: Europe Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 53: Europe Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 54: Europe Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Others, 2018-2029
Figure 55: Europe Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 3, 2022 & 2029
Figure 56: Europe Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 57: Europe Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 58: Europe Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 59: Europe Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Others, 2018-2029
Figure 60: Europe Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by U.K., 2018-2029
Figure 61: Europe Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Germany, 2018-2029
Figure 62: Europe Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by France, 2018-2029
Figure 63: Europe Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Italy, 2018-2029
Figure 64: Europe Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Spain, 2018-2029
Figure 65: Europe Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Russia, 2018-2029
Figure 66: Europe Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Rest of Europe, 2018-2029
Figure 67: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 1, 2022 & 2029
Figure 68: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 69: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 70: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 2, 2022 & 2029
Figure 71: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 72: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 73: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 74: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Others, 2018-2029
Figure 75: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 3, 2022 & 2029
Figure 76: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 77: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 78: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 79: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Others, 2018-2029
Figure 80: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by China, 2018-2029
Figure 81: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by India, 2018-2029
Figure 82: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Japan, 2018-2029
Figure 83: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Australia, 2018-2029
Figure 84: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Southeast Asia, 2018-2029
Figure 85: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Rest of Asia Pacific, 2018-2029
Figure 86: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 1, 2022 & 2029
Figure 87: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 88: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 89: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 2, 2022 & 2029
Figure 90: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 91: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 92: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 93: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Others, 2018-2029
Figure 94: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Value Share (%), By Segment 3, 2022 & 2029
Figure 95: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 1, 2018-2029
Figure 96: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 2, 2018-2029
Figure 97: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Sub-Segment 3, 2018-2029
Figure 98: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Others, 2018-2029
Figure 99: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by GCC, 2018-2029
Figure 100: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by South Africa, 2018-2029
Figure 101: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Forecast (USD Billion), by Rest of Middle East & Africa, 2018-2029
List of Tables
Table 1: Global Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 1, 2018-2029
Table 2: Global Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 2, 2018-2029
Table 3: Global Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 3, 2018-2029
Table 4: Global Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Region, 2018-2029
Table 5: North America Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 1, 2018-2029
Table 6: North America Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 2, 2018-2029
Table 7: North America Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 3, 2018-2029
Table 8: North America Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Country, 2018-2029
Table 9: Europe Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 1, 2018-2029
Table 10: Europe Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 2, 2018-2029
Table 11: Europe Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 3, 2018-2029
Table 12: Europe Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Country, 2018-2029
Table 13: Latin America Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 1, 2018-2029
Table 14: Latin America Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 2, 2018-2029
Table 15: Latin America Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 3, 2018-2029
Table 16: Latin America Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Country, 2018-2029
Table 17: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 1, 2018-2029
Table 18: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 2, 2018-2029
Table 19: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 3, 2018-2029
Table 20: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Country, 2018-2029
Table 21: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 1, 2018-2029
Table 22: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 2, 2018-2029
Table 23: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Segment 3, 2018-2029
Table 24: Middle East & Africa Monoclonal Antibody Diagnostic Reagent Market Revenue (USD Billion) Forecast, by Country, 2018-2029